✦ LIBER ✦
Letter to the Editor referring to the manuscript entitled: “Phase II trial of trastuzumab in women with advanced or recurrent HER-positive endometrial carcinoma: a Gynecologic Oncology Group study” recently reported by Fleming et al., (Gynecol Oncol., 116;15–20;2010)
✍ Scribed by Alessandro D. Santin
- Book ID
- 113962415
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 78 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.